SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-049963
Filing Date
2018-08-07
Accepted
2018-08-07 06:01:11
Documents
6
Period of Report
2018-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18323_38k.htm 8-K 30346
2 EX-4.1 a18-18323_3ex4d1.htm EX-4.1 103082
3 EX-4.2 a18-18323_3ex4d2.htm EX-4.2 102649
4 EX-4.3 a18-18323_3ex4d3.htm EX-4.3 103636
5 EX-5.1 a18-18323_3ex5d1.htm EX-5.1 11398
6 GRAPHIC g183233kgi001.gif GRAPHIC 1275
  Complete submission text file 0001104659-18-049963.txt   354390
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 18996175
SIC: 2834 Pharmaceutical Preparations